Across TCGA pan-cancer cohorts, POR mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated POR data layer compared with 23 for mass-spec protein and 8 for mutation status.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher POR mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated POR expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.
CCRCC, HNSC, and PDAC are the cancer types where POR mass-spec protein most reproducibly stratifies survival.